Evidence map›Paper›PMID 38667965›Full record

ReviewJournal of fungi (Basel, Switzerland)2024

Terenzio Cosio, Francesca Pica, Carla Fontana, Enrico Salvatore Pistoia, Marco Favaro, Isabel Valsecchi, Nikkia Zarabian, Elena Campione, Françoise Botterel, Roberta Gaziano

Open access · goldAbstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. When "Medical mycology case reports · 2026
    Article
  3. Article
  4. Article
  5. The Prevalence and Drug Susceptibility ofAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Impact ofPathogens (Basel, Switzerland) · 2025
    Observational
  7. Review
  8. Trend ofCurrent medical mycology · 2025
    Article
  9. Article
  10. Analysis of Antifungal Drug Resistance AmongInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Terenzio CosioDepartment of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0003-4025-7882
Francesca PicaDepartment of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0002-7899-889X
Carla FontanaLaboratory of Microbiology and BioBank, National Institute for Infectious Diseases "Lazzaro Spallanzani" I.R.C.C.S., 00149 Rome, Italy.ORCID 0000-0003-2198-1947
Enrico Salvatore PistoiaDepartment of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
Marco FavaroDepartment of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
Isabel ValsecchiDYNAMYC 7380, Faculté de Santé, Université Paris-Est Créteil (UPEC), 94010 Créteil, France.
Nikkia ZarabianSchool of Medicine and Health Sciences, George Washington University, 2300 I St NW, Washington, DC 20052, USA.
Elena CampioneDermatology Unit, Department of Systems Medicine, Tor Vergata University Hospital, 00133 Rome, Italy.
Françoise BotterelDYNAMYC 7380, Faculté de Santé, Université Paris-Est Créteil (UPEC), 94010 Créteil, France.ORCID 0000-0002-3028-2665
Roberta GazianoDepartment of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0003-1970-2670
University of Rome Tor Vergata · ITUniversité Paris-Est Créteil · FRGeorge Washington University · USIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the incidence of fungal infections in humans has increased dramatically, accompanied by an expansion in the number of species implicated as etiological agents, especially environmental fungi never involved before in human infection. Among fungal pathogens,

Indexed as

antifungal agentsantifungal resistanceCandida ciferriifungal infectionsimmunosuppressionStephanoascus ciferrii complexyeast

Identifiers

PMID38667965
PMCPMC11050938
OpenAlexW4394919139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.